1 Occurrence of carbapenemase-producing Enterobacteriaceae in a Portuguese river: bla, bla and bla among the detected genes.

2 Oral Treatments With Probiotics and Live Vaccine Induce Unique Changes in Gut Neurochemicals and Microbiome in Chickens.

3 Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Enterobacteriaceae- related urinary tract infections.

4 Extract Rejuvenates the Activity of Phenicols on Selected Multi Drug Resistant Strains.

5 frecuencia de enzimas asociadas a sensibilidad disminuida a betalactámicos en aislados de enterobacterias, caracas, venezuela frequency of enzymes associated with reduced sensitivity to beta-lactam antibiotics in enterobacteria isolates, caracas, venezuela

6 extended-spectrum β-lactamase-producing enterobacteriaceae in community-acquired urinary tract infections in são luís, brazil

7 clinical usefulness of klebsiella pneumoniae carbapenemase-producing k. pneumoniae genotyping: the experience of a single-center epidemic

8 susceptibilidad a betalactámicos y resistencia por betalactamasas de espectro extendido (blee) en enterobacteriaceae aisladas de reservorios ambientales de un hospital general en cajamarca, perú.*

9 biocluster: tool for identification and clustering of enterobacteriaceae based on biochemical data

10 occurrence of antimicrobial-resistant enterobacteriaceae in water from different sources in a subtropical region of argentina

11 long-term warming shifts the composition of bacterial communities in the phyllosphere of galium album in a permanent grassland field-experiment

12 prevalence of extended-spectrum beta-lactamases-producing microorganisms in nosocomial patients and molecular characterization of the shv type isolates

13 impact of the introduction of an automated microbiologic system on the clinical outcomes of bloodstream infections caused by enterobacteriaceae strains

14 identification and characterization of t5-like bacteriophages representing two novel subgroups from food products

15 occurrence of class 1 and 2 integrons in enterobacteriaceae collected from zagazig university hospitals, egypt

16 antibiotic resistance of enterobacteriaceae strains isolated from different animals gastrointestinal tracts

17 carbapenem-resistant klebsiella pneumoniae isolates from egypt containing blandm-1 on incr plasmids and its association with rmtf

18 Survey of US wastewater for carbapenem-resistant Enterobacteriaceae.

19 Psychoactive drug prescription and urine colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae

20 Impact of individualized active surveillance of carbapenem-resistant enterobacteriaceae on the infection rate in intensive care units: a 3-year retrospective study in a teaching hospital of People’s Republic of China

21 Simulating moxalactam dosage for extended-spectrum β-lactamase-producing Enterobacteriaceae using blood antimicrobial surveillance network data

22 Molecular mechanisms related to colistin resistance in Enterobacteriaceae

23 Epidemiology of carbapenem-resistant Enterobacteriaceae: a 5-year experience at a tertiary care hospital

24 Simultaneous three Enterobacteriaceae with different bla NDM-1-encoding plasmids in a patient transferred from mainland China to Taiwan

25 Relation between flomoxef minimum inhibitory concentrations and clinical outcomes of patients treated with flomoxef for Enterobacteriaceae bacteremia

26 Ertapenem non-susceptibility and independent predictors of the carbapenemase production among the Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)

27 Overview of meropenem-vaborbactam and newer antimicrobial agents for the treatment of carbapenem-resistant Enterobacteriaceae

28 Epidemiology of and risk factors for infection with extended-spectrum β-lactamase-producing carbapenem-resistant Enterobacteriaceae: results of a double case–control study

29 The prevalence of plasmid-mediated quinolone resistance and ESBL-production in Enterobacteriaceae isolated from urinary tract infections

30 Mecillinam for the treatment of acute pyelonephritis and bacteremia caused by Enterobacteriaceae: a literature review

31 Ugly bugs in healthy guts! Carriage of multidrug-resistant and ESBL-producing commensal Enterobacteriaceae in the intestine of healthy Nepalese adults

32 Clinical benefit of ertapenem compared to flomoxef for the treatment of cefotaxime-resistant Enterobacteriaceae bacteremia

33 Contribution of horizontal gene transfer to the emergence of VIM-4 carbapenemase producer Enterobacteriaceae in Kuwait

34 Frequency of colistin and fosfomycin resistance in carbapenem-resistant Enterobacteriaceae from a tertiary care hospital in Karachi

35 Extended-spectrum beta-lactamase- and carbapenemase-producing Enterobacteriaceae among Ethiopian children

36 Fecal carriage of CTX-M β-lactamase-producing Enterobacteriaceae in nursing homes in the Kinki region of Japan

37 Psychoactive drug prescription and urine colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae

38 Psychoactive drug prescription and urine colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae

39 Impact of individualized active surveillance of carbapenem-resistant enterobacteriaceae on the infection rate in intensive care units: a 3-year retrospective study in a teaching hospital of People’s Republic of China

40 Simulating moxalactam dosage for extended-spectrum β-lactamase-producing Enterobacteriaceae using blood antimicrobial surveillance network data

41 Molecular mechanisms related to colistin resistance in Enterobacteriaceae

42 Epidemiology of carbapenem-resistant Enterobacteriaceae: a 5-year experience at a tertiary care hospital

43 Simultaneous three Enterobacteriaceae with different bla NDM-1-encoding plasmids in a patient transferred from mainland China to Taiwan

44 Relation between flomoxef minimum inhibitory concentrations and clinical outcomes of patients treated with flomoxef for Enterobacteriaceae bacteremia

45 Ertapenem non-susceptibility and independent predictors of the carbapenemase production among the Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)

46 Overview of meropenem-vaborbactam and newer antimicrobial agents for the treatment of carbapenem-resistant Enterobacteriaceae

47 Epidemiology of and risk factors for infection with extended-spectrum β-lactamase-producing carbapenem-resistant Enterobacteriaceae: results of a double case–control study

48 The prevalence of plasmid-mediated quinolone resistance and ESBL-production in Enterobacteriaceae isolated from urinary tract infections

49 Mecillinam for the treatment of acute pyelonephritis and bacteremia caused by Enterobacteriaceae: a literature review

50 Ugly bugs in healthy guts! Carriage of multidrug-resistant and ESBL-producing commensal Enterobacteriaceae in the intestine of healthy Nepalese adults

51 Clinical benefit of ertapenem compared to flomoxef for the treatment of cefotaxime-resistant Enterobacteriaceae bacteremia

52 Contribution of horizontal gene transfer to the emergence of VIM-4 carbapenemase producer Enterobacteriaceae in Kuwait

53 Frequency of colistin and fosfomycin resistance in carbapenem-resistant Enterobacteriaceae from a tertiary care hospital in Karachi

54 Extended-spectrum beta-lactamase- and carbapenemase-producing Enterobacteriaceae among Ethiopian children

55 Fecal carriage of CTX-M β-lactamase-producing Enterobacteriaceae in nursing homes in the Kinki region of Japan

56 Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia.

57 Efficacy of ceftazidime-avibactam in the treatment of infections due to Carbapenem-resistant Enterobacteriaceae.

58 Prevalence and dissemination risk of antimicrobial-resistant Enterobacteriaceae from shared bikes in Beijing, China.

59 Characteristics of ESLB-producing enterobacteriaceae and methicillinresistant Staphylococcus aureus (MRSA) isolated from Swiss and imported raw poultry meat collected at retail level

60 Characterization of Carbapenem-Resistant Enterobacteriaceae Clinical Isolates in Al Thawra University Hospital, Sana'a, Yemen.

61 Implementing a toolkit for the prevention, management and control of carbapenemase-producing Enterobacteriaceae in English acute hospitals trusts: a qualitative evaluation.

62 Treatment of carbapenem-resistant enterobacteriaceae infections: Is there anything else?

63 Decreasing prevalence of contamination with extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) in retail chicken meat in the Netherlands.

64 Plazomicin for Infections Caused by Carbapenem-Resistant Enterobacteriaceae.

65 Comparison of three methods for identification of Enterobacteriaceae

66 Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs)

67 Antimicrobials Increase Travelers' Risk of Colonization by Extended-Spectrum Betalactamase-Producing Enterobacteriaceae

68 study on mics of tigecycline in clinical isolates of carbapenem resistant enterobacteriaceae (cre) at a tertiary care centre in north india

69 yersinia enterocolitica ve bazı enterobacteriaceae türlerinin yoğurtta canlı kalma düzeyleri (İngilizce)

70 bacteriophages contribute to the spread of antibiotic resistance genes among foodborne pathogens of the enterobacteriaceae family – a review

71 mutations in the quinolone resistance-determining regions of gyra and parc in enterobacteriaceae isolates from brazil

72 serine protease autotransporters of enterobacteriaceae (spates): biogenesis and function

73 use of a selective medium with potassium tellurite to follow intestinal colonization of hospitalized patients by drug-resistant enterobacteriaceae

74 effects of breakpoint changes on carbapenem susceptibility rates ofenterobacteriaceae: results from the sentry antimicrobial surveillance program, united states, 2008 to 2012

75 host-toxin interactions involving espc and pet, two serine protease autotransporters of the enterobacteriaceae

76 in vitro activity of cefepime/aai101 and comparators against cefepime non-susceptible enterobacteriaceae

77 nosocomial infection and characterization of extended-spectrum β-lactamases-producing enterobacteriaceae in northeast brazil

78 Enterobacillus tribolii gen. nov., sp. nov., a novel member of the family Enterobacteriaceae , isolated from the gut of a red flour beetle, Tribolium castaneum

79 A two-centre evaluation of RAPIDEC® CARBA NP for carbapenemase detection in Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter spp.

80 Performance of the EUCAST disc diffusion method and two MIC methods in detection of Enterobacteriaceae with reduced susceptibility to meropenem: the NordicAST CPE study

81 Colonization With Levofloxacin-resistant Extended-spectrum β-Lactamase-producing Enterobacteriaceae and Risk of Bacteremia in Hematopoietic Stem Cell Transplant Recipients

82 Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae

83 High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6′)-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China (Antimicrobial Agents and Chemotheraphy (2008) 52:12 (4268-4273))

84 Canadian recommendations for laboratory interpretation of multiple or extensive drug resistance in clinical isolates of Enterobacteriaceae, species and .

Keyword Connections

Journals

Research Groups

Bibliographies